SCHEMBL7417547

SCHEMBL7417547

CC(C)(C)c1ccc(S(=O)(=O)NCC(NS(=O)(=O)c2ccc(Cl)cc2)C(=O)NO)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 5/20 0.69
MMP10 P09238 1/20 0.69
MMP9 P14780 1/20 0.69
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
HDAC3 O15379 3/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
BMP1 P13497 1/20 0.46
PSMB8 P28062 1/20 0.46
PSMB5 P28074 1/20 0.46
HDAC11 Q96DB2 2/20 0.45
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
KDR P35968 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417364 1.00 MMP7 (0.69) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7419489 0.94 MMP7 (0.77) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7415251 0.90 MMP7 (0.70) MMP7MMP10MMP9CA1CA2
SCHEMBL7414393 0.89 MMP7 (0.70) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7417174 0.89 MMP7 (0.58) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7410656 0.89 MMP7 (0.58) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7416392 0.87 MMP7 (0.62) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7414877 0.86 MMP7 (0.66) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7415839 0.86 MMP7 (0.66) MMP7MMP10MMP9ALDH1A1MAPT
SCHEMBL7417827 0.84 MMP7 (0.59) MMP7MMP10MMP9CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed